首页>新闻资讯 2025-07-07 09:47:59
「同位素标记抑制剂」CAS:1227666-13-8|Nateglinide-d5
生物活性:Nateglinide-d5 is a deuterium labeled Nateglinide. Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K+ channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus[1][2].
IC50 & Target:DPP-4
体外研究(In Vitro):氢、碳和其他元素的稳定重同位素已被掺入药物分子中,主要用作药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注。
德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.
Nateglinide-d5 相关抗体:
ATP1A1 Antibody
LGI1 Antibody (YA2885)
DPP4/CD26 Antibody (YA1274)
Cardiac Troponin C Antibody (YA2125)
Cardiac Troponin T Antibody (YA2719)
SAP97 Antibody (YA2731)
Kir2.1 Antibody (YA2871)
分子量:322.45
Formula:C19H22D5NO3
CAS 号:1227666-13-8
非标记 CAS:105816-04-4
性状:固体
颜色:White to off-white
中文名称:那格列奈 d5
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years
In solvent:-80°C:6 months,-20°C:1 month
推荐新闻
-
发布时间 | 2025-11-13 11:26:08
ZSTK474 | 475110-96-4
-
发布时间 | 2025-11-13 11:26:01
Sunitinib (SU11248) malate | 341031-54-7
-
发布时间 | 2025-11-13 11:23:37
Brivanib (BMS-540215) | 649735-46-6
-
发布时间 | 2025-11-13 11:21:45
Linifanib (ABT-869) | 796967-16-3
-
发布时间 | 2025-11-13 11:21:45
Crizotinib (PF-02341066) | 877399-52-5